SHLTN fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
SHL Telemedicine Ltd. engages in the development and market of advanced personal telemedicine solutions, which focuses on cardiovascular and related diseases. Its products and solutions include congestive heart failure, chronic obstructive pulmonary disease and cardiac monitoring services. It operates through the following geographical segments: Israel, Europe principally Germany, and Rest of the World. The company was founded by Yoram Alroy and Elon Shalev in 1987 and is headquartered in Tel Aviv, Israel.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
SHLTN does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company